BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17071808)

  • 1. Pseudovascular adenoid squamous-cell carcinoma of the oral cavity--a report of two cases.
    Zidar N; Gale N; Zupevc A; Dovsak D
    J Clin Pathol; 2006 Nov; 59(11):1206-8. PubMed ID: 17071808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity.
    Bagutti C; Speight PM; Watt FM
    J Pathol; 1998 Sep; 186(1):8-16. PubMed ID: 9875134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma.
    Diniz-Freitas M; García-Caballero T; Antúnez-López J; Gándara-Rey JM; García-García A
    Oral Oncol; 2006 Feb; 42(2):190-200. PubMed ID: 16249116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator/plasmin system suppresses cell-cell adhesion of oral squamous cell carcinoma cells via proteolysis of E-cadherin.
    Hayashido Y; Hamana T; Yoshioka Y; Kitano H; Koizumi K; Okamoto T
    Int J Oncol; 2005 Sep; 27(3):693-8. PubMed ID: 16077918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta- and gamma-catenin expression in oral squamous cell carcinomas.
    Lo Muzio L; Staibano S; Pannone G; Grieco M; Mignogna MD; Cerrato A; Testa NF; De Rosa G
    Anticancer Res; 1999; 19(5B):3817-26. PubMed ID: 10628318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-cadherin, laminin and collagen IV expression in the evolution from dysplasia to oral squamous cell carcinoma.
    Santos-García A; Abad-Hernández MM; Fonseca-Sánchez E; Julián-González R; Galindo-Villardón P; Cruz-Hernández JJ; Bullón-Sopelana A
    Med Oral Patol Oral Cir Bucal; 2006 Mar; 11(2):E100-5. PubMed ID: 16505783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of alpha2-antiplasmin inhibits E-cadherin processing mediated by the plasminogen activator/plasmin system, leading to suppression of progression of oral squamous cell carcinoma via upregulation of cell-cell adhesion.
    Hayashido Y; Hamana T; Ishida Y; Shintani T; Koizumi K; Okamoto T
    Oncol Rep; 2007 Feb; 17(2):417-23. PubMed ID: 17203182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan.
    Lin CY; Hung HC; Kuo RC; Chiang CP; Kuo MY
    Oral Oncol; 2005 Jul; 41(6):645-54. PubMed ID: 15927524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of adhesion-regulated proteinase production is correlated with invasive activity in oral squamous cell carcinoma.
    Ghosh S; Munshi HG; Sen R; Linz-McGillem LA; Goldman RD; Lorch J; Green KJ; Jones JC; Stack MS
    Cancer; 2002 Dec; 95(12):2524-33. PubMed ID: 12467066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of desmosomes in oral squamous cell carcinoma: correlation with cytokeratin and E-cadherin staining, and with tumour behaviour.
    Shinohara M; Hiraki A; Ikebe T; Nakamura S; Kurahara S; Shirasuna K; Garrod DR
    J Pathol; 1998 Apr; 184(4):369-81. PubMed ID: 9664902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gains and losses of adhesion molecules (CD44, E-cadherin, and beta-catenin) during oral carcinogenesis and tumour progression.
    Bánkfalvi A; Krassort M; Buchwalow IB; Végh A; Felszeghy E; Piffkó J
    J Pathol; 2002 Nov; 198(3):343-51. PubMed ID: 12375267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudovascular adenoid squamous cell carcinoma of the skin. A neoplasm that may be mistaken for angiosarcoma.
    Nappi O; Wick MR; Pettinato G; Ghiselli RW; Swanson PE
    Am J Surg Pathol; 1992 May; 16(5):429-38. PubMed ID: 1599022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of E-cadherin gene protein in oral verrucous carcinoma].
    Tang ZG; Zou P; Xie XL
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):206-8. PubMed ID: 14653067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of clinicopathological features with immunohistochemical expression of cell cycle regulatory proteins p16 and retinoblastoma: distinct association with keratinisation and differentiation in oral cavity squamous cell carcinoma.
    Muirhead DM; Hoffman HT; Robinson RA
    J Clin Pathol; 2006 Jul; 59(7):711-5. PubMed ID: 16467168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary adenoid squamous cell carcinoma of the oral cavity.
    Kusafuka K; Ebihara M; Ishiki H; Takizawa Y; Iida Y; Onitsuka T; Takakuwa R; Kasami M; Ito I; Kameya T
    Pathol Int; 2006 Feb; 56(2):78-83. PubMed ID: 16445819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of activated Akt expression in oral squamous cell carcinoma.
    Lim J; Kim JH; Paeng JY; Kim MJ; Hong SD; Lee JI; Hong SP
    J Clin Pathol; 2005 Nov; 58(11):1199-205. PubMed ID: 16254112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome.
    Pyo SW; Hashimoto M; Kim YS; Kim CH; Lee SH; Johnson KR; Wheelock MJ; Park JU
    J Craniomaxillofac Surg; 2007 Jan; 35(1):1-9. PubMed ID: 17296306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered E-cadherin/beta-catenin expression in oral squamous carcinoma with and without nodal metastasis.
    Mahomed F; Altini M; Meer S
    Oral Dis; 2007 Jul; 13(4):386-92. PubMed ID: 17577324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-cadherin loss and Delta Np73L expression in oral squamous cell carcinomas showing aggressive behavior.
    Foschini MP; Cocchi R; Morandi L; Marucci G; Pennesi MG; Righi A; Tosi AL; de Biase D; Pession A; Montebugnoli L
    Head Neck; 2008 Nov; 30(11):1475-82. PubMed ID: 18704970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-cadherin expression reduced in squamous cell carcinoma of the oral cavity: an indicatior of poor prognosis.
    Muñoz-Guerra MF; Marazuela EG; Fernández-Contreras ME; Gamallo C
    Cancer; 2005 Mar; 103(5):960-9. PubMed ID: 15685613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.